1. To establish clinical efficacy, safety and patient satisfaction of reducing lower eyelid convexities or "bags" and/or malar crescents (festoons) with catheter-based injectable RF (InMode AccuTite) and variable depth Fractional RF Microneedle skin rejuvenation (InMode Morpheus8). 2. To determine the relative effectiveness of dual-modality treatment (AccuTite + Morphues8 initial treatment followed by two consecutive Morpheus8 treatments 1 month apart) versus single modality treatment (AccuTite only)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Correct identification at baseline and post treatment pictures
Timeframe: Change from baseline at 3 and 6 months
Change in lower eyelid convexity scale
Timeframe: Change from baseline at 3 and 6 months
Change in Festoonage scale
Timeframe: Change from baseline at 3 and 6 months
Subject assessment of satisfaction
Timeframe: Change from baseline at 3 and 6 months